Europe Biological Data Visualization Market To Reach $445.4 Million by 2035

European biological data visualization market stood at $205.7 million in 2025 and is expected to grow to $445.4 million by 2035, registering a CAGR of 8.1% from 2026 to 2035, according to a new report by OMR Global. European governments and research consortia are investing heavily in large-scale genomic data generation, federated data infrastructures, and cross-border data access frameworks that directly increase the need for biological data visualization tools. A cornerstone of this effort is the 1+Million Genomes (1+MG) Initiative, which aims to create secure, federated access to genomic and health data across European countries to improve research, personalized medicine, and healthcare outcomes. The initiative’s 2023-2027 Roadmap outlines the deployment of interoperable technical infrastructure and governance frameworks that will enable researchers to visualize and analyze complex genomic datasets spanning multiple nations. This growing infrastructure backbone is creating demand for advanced visualization capabilities that can integrate genomic, clinical, and phenotypic data at scale.

Browse the full report description of “European Biological Data Visualization Market Size, Share & Trends Analysis Report by Technique (Magnetic Resonance Imaging, Microscopy, Sequencing, and Others), By Application (Genomic Analysis, Cell Biology, Molecular & Structural Analysis, and Others), By End-User (Pharmaceutical & Biotechnology Companies, Research Institutes, Hospitals, and Clinics) Forecast Period 2026-2035” of https://www.omrglobal.com/industry-reports/europe-biological-data-visualization-market

Concrete progress under these initiatives highlights their impact on data accessibility and visualization demand. By 2024, at least six EU countries had implemented common data specifications under the 1+MG framework, enabling secure genomic data access, while 15 countries are expected to have operational infrastructure by 2026. The Genome of Europe (GoE) project, launched in late 2024 with about €45 million in funding, will build a pan-European reference genome dataset of at least 100,000 genomes, facilitating large cohort visualization and comparative analysis across diverse European populations. Federated infrastructures such as the European Genomic Data Infrastructure (GDI) are designed to make these datasets accessible for cross-border research and integrative visual exploration.

QIAGEN Advances Multiomics and NGS Workflows with New Kits and Partnerships

• In November 2023, QIAGEN and Element Biosciences partnered to provide comprehensive NGS workflows for Element's AVITI System, a versatile benchtop sequencer. QIAGEN will supply validated QIAseq panels and integrated bioinformatics tools like CLC LightSpeed and QCI Interpret, enhancing performance, cost-efficiency, and flexibility for various NGS applications.
• In May 2024, QIAGEN introduced the QIAseq Multimodal DNA/RNA Library Kit, allowing simultaneous preparation of DNA and RNA libraries from a single sample for next-generation sequencing, including whole genome and transcriptome analysis. The kit streamlines multiomics workflows, reduces sample requirements, and shortens preparation time compared to separate DNA and RNA sequencing approaches.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • Technique
  • Application
  • End-User
• Competitive Landscape – Agilent Technologies, Inc., Danaher Corp., Illumina, Inc., QIAGEN N.V., Thermo Fisher Scientific, Inc., among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Europe Biological Data Visualization Market Report Segment

By Technique

• Magnetic Resonance Imaging
• Microscopy
• Sequencing
• Others

By Application

• Genomic Analysis
• Cell Biology
• Molecular and Structural Analysis
• Others

By End-User

• Pharmaceutical & Biotechnology Companies
• Research Institutes
• Hospitals and Clinics

Europe Biological Data Visualization Market Report Segment by Country

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/europe-biological-data-visualization-market